1. Home
  2. EOLS vs UAN Comparison

EOLS vs UAN Comparison

Compare EOLS & UAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOLS
  • UAN
  • Stock Information
  • Founded
  • EOLS 2012
  • UAN 2007
  • Country
  • EOLS United States
  • UAN United States
  • Employees
  • EOLS N/A
  • UAN N/A
  • Industry
  • EOLS Biotechnology: Pharmaceutical Preparations
  • UAN Agricultural Chemicals
  • Sector
  • EOLS Health Care
  • UAN Industrials
  • Exchange
  • EOLS Nasdaq
  • UAN Nasdaq
  • Market Cap
  • EOLS 854.0M
  • UAN 799.2M
  • IPO Year
  • EOLS 2018
  • UAN 2011
  • Fundamental
  • Price
  • EOLS $12.05
  • UAN $75.20
  • Analyst Decision
  • EOLS Strong Buy
  • UAN
  • Analyst Count
  • EOLS 4
  • UAN 0
  • Target Price
  • EOLS $24.67
  • UAN N/A
  • AVG Volume (30 Days)
  • EOLS 736.2K
  • UAN 21.1K
  • Earning Date
  • EOLS 03-04-2025
  • UAN 04-28-2025
  • Dividend Yield
  • EOLS N/A
  • UAN 9.03%
  • EPS Growth
  • EOLS N/A
  • UAN N/A
  • EPS
  • EOLS N/A
  • UAN 5.76
  • Revenue
  • EOLS $266,274,000.00
  • UAN $525,323,999.00
  • Revenue This Year
  • EOLS $34.56
  • UAN N/A
  • Revenue Next Year
  • EOLS $32.26
  • UAN N/A
  • P/E Ratio
  • EOLS N/A
  • UAN $13.10
  • Revenue Growth
  • EOLS 31.76
  • UAN N/A
  • 52 Week Low
  • EOLS $9.25
  • UAN $62.94
  • 52 Week High
  • EOLS $17.82
  • UAN $88.94
  • Technical
  • Relative Strength Index (RSI)
  • EOLS 35.35
  • UAN 43.59
  • Support Level
  • EOLS $13.07
  • UAN $74.85
  • Resistance Level
  • EOLS $13.66
  • UAN $76.38
  • Average True Range (ATR)
  • EOLS 0.58
  • UAN 1.52
  • MACD
  • EOLS -0.15
  • UAN 0.12
  • Stochastic Oscillator
  • EOLS 22.22
  • UAN 54.47

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

About UAN CVR Partners LP Common Units representing Limited Partner Interests

CVR Partners LP is a manufacturer and supplier of nitrogen fertilizer products. Its principal products include Urea Ammonium Nitrate (UAN) and ammonia. The company market ammonia products to industrial and agricultural customers and UAN products to agricultural customers. The primary geographic markets for its fertilizer products are Kansas, Missouri, Nebraska, Iowa, Illinois, Colorado, and Texas. The company's product sales are heavily weighted toward UAN.

Share on Social Networks: